1. Formulation of enterosoluble microparticles for an acid labile protein;Alavi;J. Pharm. Pharm. Sci.,2002
2. Microparticles for delivering therapeutic peptides and proteins to the lumen of the small intestine;Amorim;Eur. J. Pharm. Sci.,2001
3. Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics;Arangoa;Pharm. Res.,2001
4. Handbook of Solubility Parameters and Other Cohesion Parameters;Barton,1983
5. CDER, Guidance for Industry Q3C Impurities: Residual Solvents. http://www.fda.gov/cder/guidance/Q3Cfinal.htm.